Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

The normal human prostate does not significantly affect blood DHT levels.

New compounds may soon be tested to treat excessive hair growth in women.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Quick treatment of hair disorders in teenage girls is important because of the emotional effects.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Moderately high prolactin levels do not cause hair loss in women.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Primary care for PCOS focuses on lifestyle changes, medication based on symptoms, and mental health, with diabetes screening and specialist referral for severe cases.

Metformin helps manage diabetes, PCOS, and weight in kids but needs more research for long-term safety.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

The article concludes that global standardization in PCOS research is crucial for accurate diagnosis and understanding of the condition.

Measuring the distance from the anus to the clitoris may moderately help diagnose polycystic ovary syndrome, especially in certain cases.

Treat pattern hair loss with finasteride and topical minoxidil.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

Testosterone helps human pancreatic cells increase insulin release.

Statins may be linked to reproductive organ conditions, and their risks should be monitored.